TITLE:
Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

CONDITION:
Measles

INTERVENTION:
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks

SUMMARY:

      The purpose of this study is to demonstrate that an investigational refrigerated vaccine
      with measles, mumps, rubella, and varicella is well tolerated and has similar immune
      response when compared to a frozen vaccine with measles, mumps, rubella, and varicella.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 12 Months to 23 Months
Criteria:

        Inclusion Criteria:

          -  Healthy children 12-23 months of age

        Exclusion Criteria:

          -  Previously had measles, mumps, rubella, or varicella

          -  Compromised immune system
      
